Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia

BACKGROUND: Georgia has one of the highest HCV prevalence in the world and launched the world’s first national HCV elimination programs in 2015. Georgia set the ambitious target of diagnosing 90% of people living with HCV, treating 95% of those diagnosed and curing 95% of treated patients by 2020. W...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Infect Dis
Main Authors: Tsertsvadze, Tengiz, Gamkrelidze, Amiran, Nasrullah, Muazzam, Sharvadze, Lali, Morgan, Juliette, Shadaker, Shaun, Gvinjilia, Lia, Butsashvili, Maia, Metreveli, David, Kerashvili, Vakhtang, Ezugbaia, Marina, Chkhartishvili, Nikoloz, Abutidze, Akaki, Kvaratskhelia, Valeri, Averhoff, Francisco
格式: Artigo
語言:Inglês
出版: BioMed Central 2020
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954615/
https://ncbi.nlm.nih.gov/pubmed/31924172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-019-4741-5
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍